APP
HALO icon

Alpha Paradigm Partners’s Halozyme HALO Stock Holding History

Alpha Paradigm Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$362K Sell
6,357
-16,742
-72% -$857K 0.15% 215
2022
Q3 		$913K Buy
+23,099
New +$1.02M 0.4% 70

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Paradigm Partners's HALO Position: Q4 2022 in Review

Alpha Paradigm Partners reduced its Halozyme (HALO) stake by 72% in Q4 2022, selling an estimated $857K and leaving 6,357 shares worth $362K. The position accounts for 0.15% of the portfolio, ranked #215.

Alpha Paradigm Partners first reported a position in HALO in Q3 2022 and has held it in 2 quarters since. The position peaked at $913K in Q3 2022. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Alpha Paradigm Partners held 6,357 shares of Halozyme worth $362K as of Q4 2022.
  • Alpha Paradigm Partners sold 16,742 Halozyme shares in Q4 2022, an estimated $857K.
  • Halozyme made up 0.15% of Alpha Paradigm Partners's portfolio in Q4 2022, its #215 holding.
  • Alpha Paradigm Partners first reported a position in Halozyme in Q3 2022 and has held it in 2 quarters since.
  • Alpha Paradigm Partners's Halozyme position peaked at $913K in Q3 2022.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.